Your payment is in progress...
  +1 (704) 266-3234

Global And United States Equine Influenza Vaccine Market Insights, Forecast To 2026

Published on: Oct 2020 | From USD $3900 | Published By: QY RESEARCH | Number Of Pages: 130

Equine Influenza Vaccine market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Equine Influenza Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Equine Influenza Vaccine market is segmented into
Liquid
Powder

Segment by Application, the Equine Influenza Vaccine market is segmented into
Home
Pet Clinic
Other

Regional and Country-level Analysis
The Equine Influenza Vaccine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Equine Influenza Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Equine Influenza Vaccine Market Share Analysis
Equine Influenza Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Equine Influenza Vaccine business, the date to enter into the Equine Influenza Vaccine market, Equine Influenza Vaccine product introduction, recent developments, etc.
The major vendors covered:
Zoetis
Merck Animal Health
Boehringer Ingelheim Vetmedica
...

1 Study Coverage
1.1 Equine Influenza Vaccine Product Introduction
1.2 Market Segments
1.3 Key Equine Influenza Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Equine Influenza Vaccine Market Size Growth Rate by Type
1.4.2 Liquid
1.4.3 Powder
1.5 Market by Application
1.5.1 Global Equine Influenza Vaccine Market Size Growth Rate by Application
1.5.2 Home
1.5.3 Pet Clinic
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Equine Influenza Vaccine Market Size, Estimates and Forecasts
2.1.1 Global Equine Influenza Vaccine Revenue 2015-2026
2.1.2 Global Equine Influenza Vaccine Sales 2015-2026
2.2 Global Equine Influenza Vaccine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Equine Influenza Vaccine Historical Market Size by Region (2015-2020)
2.3.1 Global Equine Influenza Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Equine Influenza Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Equine Influenza Vaccine Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Equine Influenza Vaccine Sales Forecast by Region (2021-2026)
2.4.2 Global Equine Influenza Vaccine Revenue Forecast by Region (2021-2026)

3 Global Equine Influenza Vaccine Competitor Landscape by Players
3.1 Global Top Equine Influenza Vaccine Sales by Manufacturers
3.1.1 Global Equine Influenza Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Global Equine Influenza Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Global Equine Influenza Vaccine Manufacturers by Revenue
3.2.1 Global Equine Influenza Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Global Equine Influenza Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Equine Influenza Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Equine Influenza Vaccine Revenue in 2019
3.2.5 Global Equine Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Equine Influenza Vaccine Price by Manufacturers
3.4 Global Equine Influenza Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Equine Influenza Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Equine Influenza Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Equine Influenza Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Equine Influenza Vaccine Market Size by Type (2015-2020)
4.1.1 Global Equine Influenza Vaccine Sales by Type (2015-2020)
4.1.2 Global Equine Influenza Vaccine Revenue by Type (2015-2020)
4.1.3 Equine Influenza Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Equine Influenza Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Equine Influenza Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Equine Influenza Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Equine Influenza Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Equine Influenza Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Equine Influenza Vaccine Market Size by Application (2015-2020)
5.1.1 Global Equine Influenza Vaccine Sales by Application (2015-2020)
5.1.2 Global Equine Influenza Vaccine Revenue by Application (2015-2020)
5.1.3 Equine Influenza Vaccine Price by Application (2015-2020)
5.2 Equine Influenza Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Equine Influenza Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Equine Influenza Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Equine Influenza Vaccine Price Forecast by Application (2021-2026)

6 United States by Players, Type and Application
6.1 United States Equine Influenza Vaccine Market Size YoY Growth 2015-2026
6.1.1 United States Equine Influenza Vaccine Sales YoY Growth 2015-2026
6.1.2 United States Equine Influenza Vaccine Revenue YoY Growth 2015-2026
6.1.3 United States Equine Influenza Vaccine Market Share in Global Market 2015-2026
6.2 United States Equine Influenza Vaccine Market Size by Players (International and Local Players)
6.2.1 United States Top Equine Influenza Vaccine Players by Sales (2015-2020)
6.2.2 United States Top Equine Influenza Vaccine Players by Revenue (2015-2020)
6.3 United States Equine Influenza Vaccine Historic Market Review by Type (2015-2020)
6.3.1 United States Equine Influenza Vaccine Sales Market Share by Type (2015-2020)
6.3.2 United States Equine Influenza Vaccine Revenue Market Share by Type (2015-2020)
6.3.3 United States Equine Influenza Vaccine Price by Type (2015-2020)
6.4 United States Equine Influenza Vaccine Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Equine Influenza Vaccine Sales Forecast by Type (2021-2026)
6.4.2 United States Equine Influenza Vaccine Revenue Forecast by Type (2021-2026)
6.4.3 United States Equine Influenza Vaccine Price Forecast by Type (2021-2026)
6.5 United States Equine Influenza Vaccine Historic Market Review by Application (2015-2020)
6.5.1 United States Equine Influenza Vaccine Sales Market Share by Application (2015-2020)
6.5.2 United States Equine Influenza Vaccine Revenue Market Share by Application (2015-2020)
6.5.3 United States Equine Influenza Vaccine Price by Application (2015-2020)
6.6 United States Equine Influenza Vaccine Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Equine Influenza Vaccine Sales Forecast by Application (2021-2026)
6.6.2 United States Equine Influenza Vaccine Revenue Forecast by Application (2021-2026)
6.6.3 United States Equine Influenza Vaccine Price Forecast by Application (2021-2026)

7 North America
7.1 North America Equine Influenza Vaccine Market Size YoY Growth 2015-2026
7.2 North America Equine Influenza Vaccine Market Facts & Figures by Country
7.2.1 North America Equine Influenza Vaccine Sales by Country (2015-2020)
7.2.2 North America Equine Influenza Vaccine Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada

8 Europe
8.1 Europe Equine Influenza Vaccine Market Size YoY Growth 2015-2026
8.2 Europe Equine Influenza Vaccine Market Facts & Figures by Country
8.2.1 Europe Equine Influenza Vaccine Sales by Country
8.2.2 Europe Equine Influenza Vaccine Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia

9 Asia Pacific
9.1 Asia Pacific Equine Influenza Vaccine Market Size YoY Growth 2015-2026
9.2 Asia Pacific Equine Influenza Vaccine Market Facts & Figures by Country
9.2.1 Asia Pacific Equine Influenza Vaccine Sales by Region (2015-2020)
9.2.2 Asia Pacific Equine Influenza Vaccine Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam

10 Latin America
10.1 Latin America Equine Influenza Vaccine Market Size YoY Growth 2015-2026
10.2 Latin America Equine Influenza Vaccine Market Facts & Figures by Country
10.2.1 Latin America Equine Influenza Vaccine Sales by Country
10.2.2 Latin America Equine Influenza Vaccine Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Equine Influenza Vaccine Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Equine Influenza Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa Equine Influenza Vaccine Sales by Country
11.2.2 Middle East and Africa Equine Influenza Vaccine Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 Zoetis
12.1.1 Zoetis Corporation Information
12.1.2 Zoetis Description and Business Overview
12.1.3 Zoetis Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Zoetis Equine Influenza Vaccine Products Offered
12.1.5 Zoetis Recent Development
12.2 Merck Animal Health
12.2.1 Merck Animal Health Corporation Information
12.2.2 Merck Animal Health Description and Business Overview
12.2.3 Merck Animal Health Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Merck Animal Health Equine Influenza Vaccine Products Offered
12.2.5 Merck Animal Health Recent Development
12.3 Boehringer Ingelheim Vetmedica
12.3.1 Boehringer Ingelheim Vetmedica Corporation Information
12.3.2 Boehringer Ingelheim Vetmedica Description and Business Overview
12.3.3 Boehringer Ingelheim Vetmedica Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Boehringer Ingelheim Vetmedica Equine Influenza Vaccine Products Offered
12.3.5 Boehringer Ingelheim Vetmedica Recent Development
12.11 Zoetis
12.11.1 Zoetis Corporation Information
12.11.2 Zoetis Description and Business Overview
12.11.3 Zoetis Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Zoetis Equine Influenza Vaccine Products Offered
12.11.5 Zoetis Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 PorterÕs Five Forces Analysis
13.5 Primary Interviews with Key Equine Influenza Vaccine Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Equine Influenza Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Equine Influenza Vaccine Market Segments
Table 2. Ranking of Global Top Equine Influenza Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Equine Influenza Vaccine Market Size Growth Rate by Type 2020-2026 (K Doses) & (US$ Million)
Table 4. Major Manufacturers of Liquid
Table 5. Major Manufacturers of Powder
Table 6. Global Equine Influenza Vaccine Market Size Growth Rate by Application 2020-2026 (K Doses)
Table 7. Global Equine Influenza Vaccine Market Size by Region (K Doses) & (US$ Million): 2020 VS 2026
Table 8. Global Equine Influenza Vaccine Sales by Regions 2015-2020 (K Doses)
Table 9. Global Equine Influenza Vaccine Sales Market Share by Regions (2015-2020)
Table 10. Global Equine Influenza Vaccine Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Equine Influenza Vaccine Sales Forecast by Region (2021-2026) (K Doses)
Table 12. Global Equine Influenza Vaccine Sales by Manufacturers (2015-2020) (K Doses)
Table 13. Global Equine Influenza Vaccine Sales Share by Manufacturers (2015-2020)
Table 14. Global Equine Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Equine Influenza Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Equine Influenza Vaccine as of 2019)
Table 16. Equine Influenza Vaccine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Equine Influenza Vaccine Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Equine Influenza Vaccine Price (2015-2020) (USD/Dose)
Table 19. Equine Influenza Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Equine Influenza Vaccine Product Type
Table 21. Date of International Manufacturers Enter into Equine Influenza Vaccine Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Equine Influenza Vaccine Sales by Type (2015-2020) (K Doses)
Table 24. Global Equine Influenza Vaccine Sales Share by Type (2015-2020)
Table 25. Global Equine Influenza Vaccine Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Equine Influenza Vaccine Revenue Share by Type (2015-2020)
Table 27. Equine Influenza Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/Dose)
Table 28. Global Equine Influenza Vaccine Sales Share by Type (2021-2026)
Table 29. Global Equine Influenza Vaccine Sales by Application (2015-2020) (K Doses)
Table 30. Global Equine Influenza Vaccine Sales Share by Application (2015-2020)
Table 31. Global Equine Influenza Vaccine Sales Share by Application (2021-2026)
Table 32. Global Equine Influenza Vaccine Sales Market Share Forecast by Application (2021-2026)
Table 33. Global Equine Influenza Vaccine Revenue by Application (2015-2020) (US$ Million)
Table 34. Global Equine Influenza Vaccine Revenue Market Share Forecast by Application (2021-2026)
Table 35. United States Equine Influenza Vaccine Sales (K Doses) of Key Companies (2015-2020)
Table 36. United States Equine Influenza Vaccine Sales Share by Company (2015-2020)
Table 37. United States Equine Influenza Vaccine Revenue (US$ Million) by Company (2015-2020)
Table 38. United States Equine Influenza Vaccine Sales (K Doses) by Type (2015-2020)
Table 39. United States Equine Influenza Vaccine Sales Share by Type (2015-2020)
Table 40. United States Equine Influenza Vaccine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 41. United States Equine Influenza Vaccine Price (K Doses) by Type (2015-2020)
Table 42. United States Equine Influenza Vaccine Sales (K Doses) by Type (2021-2026)
Table 43. United States Equine Influenza Vaccine Sales Share by Type (2021-2026)
Table 44. United States Equine Influenza Vaccine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 45. United States Equine Influenza Vaccine Revenue Share by Type (2021-2026)
Table 46. United States Equine Influenza Vaccine Price (K Doses) by Type (2021-2026)
Table 47. United States Equine Influenza Vaccine Sales (K Doses) by Application (2015-2020)
Table 48. United States Equine Influenza Vaccine Sales Share by Application (2015-2020)
Table 49. United States Equine Influenza Vaccine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 50. United States Equine Influenza Vaccine Sales (K Doses) by Application (2021-2026)
Table 51. United States Equine Influenza Vaccine Sales Share by Application (2021-2026)
Table 52. United States Equine Influenza Vaccine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 53. United States Equine Influenza Vaccine Revenue Share by Application (2021-2026)
Table 54. North America Equine Influenza Vaccine Sales by Country (2015-2020) (K Doses)
Table 55. North America Equine Influenza Vaccine Sales Market Share by Country (2015-2020)
Table 56. North America Equine Influenza Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 57. North America Equine Influenza Vaccine Revenue Market Share by Country (2015-2020)
Table 58. Europe Equine Influenza Vaccine Sales by Country (2015-2020) (K Doses)
Table 59. Europe Equine Influenza Vaccine Sales Market Share by Country (2015-2020)
Table 60. Europe Equine Influenza Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 61. Europe Equine Influenza Vaccine Revenue Market Share by Country (2015-2020)
Table 62. Asia Pacific Equine Influenza Vaccine Sales by Region (2015-2020) (K Doses)
Table 63. Asia Pacific Equine Influenza Vaccine Sales Market Share by Region (2015-2020)
Table 64. Asia Pacific Equine Influenza Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 65. Asia Pacific Equine Influenza Vaccine Revenue Market Share by Region (2015-2020)
Table 66. Latin America Equine Influenza Vaccine Sales by Country (2015-2020) (K Doses)
Table 67. Latin America Equine Influenza Vaccine Sales Market Share by Country (2015-2020)
Table 68. Latin Americaa Equine Influenza Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 69. Latin America Equine Influenza Vaccine Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Equine Influenza Vaccine Sales by Country (2015-2020) (K Doses)
Table 71. Middle East and Africa Equine Influenza Vaccine Sales Market Share by Country (2015-2020)
Table 72. Middle East and Africa Equine Influenza Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 73. Middle East and Africa Equine Influenza Vaccine Revenue Market Share by Country (2015-2020)
Table 74. Zoetis Corporation Information
Table 75. Zoetis Description and Business Overview
Table 76. Zoetis Equine Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 77. Zoetis Equine Influenza Vaccine Product
Table 78. Zoetis Recent Development
Table 79. Merck Animal Health Corporation Information
Table 80. Merck Animal Health Description and Business Overview
Table 81. Merck Animal Health Equine Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 82. Merck Animal Health Product
Table 83. Merck Animal Health Recent Development
Table 84. Boehringer Ingelheim Vetmedica Corporation Information
Table 85. Boehringer Ingelheim Vetmedica Description and Business Overview
Table 86. Boehringer Ingelheim Vetmedica Equine Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 87. Boehringer Ingelheim Vetmedica Product
Table 88. Boehringer Ingelheim Vetmedica Recent Development
Table 89. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 90. Key Challenges
Table 91. Market Risks
Table 92. Main Points Interviewed from Key Equine Influenza Vaccine Players
Table 93. Equine Influenza Vaccine Customers List
Table 94. Equine Influenza Vaccine Distributors List
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
List of Figures
Figure 1. Equine Influenza Vaccine Product Picture
Figure 2. Global Equine Influenza Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Liquid Product Picture
Figure 4. Powder Product Picture
Figure 5. Global Equine Influenza Vaccine Sales Market Share by Application in 2020 & 2026
Figure 6. Home
Figure 7. Pet Clinic
Figure 8. Other
Figure 9. Equine Influenza Vaccine Report Years Considered
Figure 10. Global Equine Influenza Vaccine Market Size 2015-2026 (US$ Million)
Figure 11. Global Equine Influenza Vaccine Sales 2015-2026 (K Doses)
Figure 12. Global Equine Influenza Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Equine Influenza Vaccine Sales Market Share by Region (2015-2020)
Figure 14. Global Equine Influenza Vaccine Sales Market Share by Region in 2019
Figure 15. Global Equine Influenza Vaccine Revenue Market Share by Region (2015-2020)
Figure 16. Global Equine Influenza Vaccine Revenue Market Share by Region in 2019
Figure 17. Global Equine Influenza Vaccine Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Equine Influenza Vaccine Revenue in 2019
Figure 19. Equine Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Equine Influenza Vaccine Sales Market Share by Type (2015-2020)
Figure 21. Global Equine Influenza Vaccine Sales Market Share by Type in 2019
Figure 22. Global Equine Influenza Vaccine Revenue Market Share by Type (2015-2020)
Figure 23. Global Equine Influenza Vaccine Revenue Market Share by Type in 2019
Figure 24. Global Equine Influenza Vaccine Market Share by Price Range (2015-2020)
Figure 25. Global Equine Influenza Vaccine Sales Market Share by Application (2015-2020)
Figure 26. Global Equine Influenza Vaccine Sales Market Share by Application in 2019
Figure 27. Global Equine Influenza Vaccine Revenue Market Share by Application (2015-2020)
Figure 28. Global Equine Influenza Vaccine Revenue Market Share by Application in 2019
Figure 29. United States Equine Influenza Vaccine Sales Growth Rate 2015-2026 (K Doses)
Figure 30. United States Equine Influenza Vaccine Revenue Growth Rate 2015-2026 (US$ Million)
Figure 31. United States Equine Influenza Vaccine Market Share in Global Market 2015-2026
Figure 32. United States 5 and 10 Largest Equine Influenza Vaccine Players Market Share by Revenue in Equine Influenza Vaccine in 2019
Figure 33. United States Equine Influenza Vaccine Revenue Share by Type (2015-2020)
Figure 34. United States Equine Influenza Vaccine Revenue Growth Rate by Type in 2015 & 2019
Figure 35. United States Equine Influenza Vaccine Revenue Share by Application (2015-2020)
Figure 36. United States Equine Influenza Vaccine Revenue Growth Rate by Application in 2015 & 2019
Figure 37. North America Equine Influenza Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 38. North America Equine Influenza Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 39. North America Equine Influenza Vaccine Sales Market Share by Country in 2019
Figure 40. North America Equine Influenza Vaccine Revenue Market Share by Country in 2019
Figure 41. U.S. Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 42. U.S. Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Canada Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 44. Canada Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Europe Equine Influenza Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 46. Europe Equine Influenza Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe Equine Influenza Vaccine Sales Market Share by Country in 2019
Figure 48. Europe Equine Influenza Vaccine Revenue Market Share by Country in 2019
Figure 49. Germany Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 50. Germany Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. France Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 52. France Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. U.K. Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 54. U.K. Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Italy Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 56. Italy Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Russia Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 58. Russia Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Asia Pacific Equine Influenza Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 60. Asia Pacific Equine Influenza Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Equine Influenza Vaccine Sales Market Share by Region in 2019
Figure 62. Asia Pacific Equine Influenza Vaccine Revenue Market Share by Region in 2019
Figure 63. China Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 64. China Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 66. Japan Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 68. South Korea Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 70. India Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 72. Australia Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 74. Taiwan Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 76. Indonesia Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 78. Thailand Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 80. Malaysia Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 82. Philippines Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 84. Vietnam Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Latin America Equine Influenza Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 86. Latin America Equine Influenza Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Equine Influenza Vaccine Sales Market Share by Country in 2019
Figure 88. Latin America Equine Influenza Vaccine Revenue Market Share by Country in 2019
Figure 89. Mexico Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 90. Mexico Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 92. Brazil Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 94. Argentina Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Middle East and Africa Equine Influenza Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 96. Middle East and Africa Equine Influenza Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Equine Influenza Vaccine Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Equine Influenza Vaccine Revenue Market Share by Country in 2019
Figure 99. Turkey Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 100. Turkey Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 102. Saudi Arabia Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 104. U.A.E Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Porter's Five Forces Analysis
Figure 106. Equine Influenza Vaccine Value Chain
Figure 107. Channels of Distribution
Figure 108. Distributors Profiles
Figure 109. Bottom-up and Top-down Approaches for This Report
Figure 110. Data Triangulation
Figure 111. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $3900
USD $5850
USD $7800
Offer

Why Us

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.